92 related articles for article (PubMed ID: 30020823)
21. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
22. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.
Guo Y; Shu L; Zhang C; Su ZY; Kong AN
Biochem Pharmacol; 2015 Mar; 94(2):69-78. PubMed ID: 25640947
[TBL] [Abstract][Full Text] [Related]
23. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
25. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Nagasawa T; Zhang Q; Raghunath PN; Wong HY; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook AH; Vonderheid EC; Odum N; Wasik MA
Leuk Res; 2006 Mar; 30(3):303-12. PubMed ID: 16185764
[TBL] [Abstract][Full Text] [Related]
26. Alterations in promoter methylation status of tumor suppressor HIC1, SFRP2, and DAPK1 genes in prostate carcinomas.
Kilinc D; Ozdemir O; Ozdemir S; Korgali E; Koksal B; Uslu A; Gultekin YE
DNA Cell Biol; 2012 May; 31(5):826-32. PubMed ID: 22136354
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of DLEC1 in sinonasal inverted papilloma and squamous cell carcinoma.
Chang PH; Huang CC; Lee TJ; Lee YS; Tsai CN
J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):94-101. PubMed ID: 22569009
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.
Kwong J; Chow LS; Wong AY; Hung WK; Chung GT; To KF; Chan FL; Daigo Y; Nakamura Y; Huang DP; Lo KW
Genes Chromosomes Cancer; 2007 Feb; 46(2):171-80. PubMed ID: 17099870
[TBL] [Abstract][Full Text] [Related]
29. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer.
Yu T; Chen X; Zhang W; Liu J; Avdiushko R; Napier DL; Liu AX; Neltner JM; Wang C; Cohen D; Liu C
Cell Death Differ; 2016 Feb; 23(2):207-15. PubMed ID: 26113043
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
31. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas.
Huskova H; Korecka K; Karban J; Vargova J; Vargova K; Dusilkova N; Trneny M; Stopka T
Int J Hematol; 2015 Oct; 102(4):441-50. PubMed ID: 26261072
[TBL] [Abstract][Full Text] [Related]
33. Role of Methylation in the Regulation of Apoptosis Genes APAF1, DAPK1, and BCL2 in Breast Cancer.
Loginov VI; Pronina IV; Burdennyi AM; Pereyaslova EA; Braga EA; Kazubskaya TP; Kushlinskii NE
Bull Exp Biol Med; 2017 Apr; 162(6):797-800. PubMed ID: 28429233
[TBL] [Abstract][Full Text] [Related]
34. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma.
Wei DM; Liu DY; Lei DP; Jin T; Wang J; Pan XL
Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179
[TBL] [Abstract][Full Text] [Related]
38. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of Death-Associated Protein Kinase (DAPK1) and its association with oral carcinogenesis - An experimental and meta-analysis study.
Jayaprakash C; Varghese VK; Bellampalli R; Radhakrishnan R; Ray S; Kabekkodu SP; Satyamoorthy K
Arch Oral Biol; 2017 Aug; 80():117-129. PubMed ID: 28412611
[TBL] [Abstract][Full Text] [Related]
40. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]